BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.
Based on our proprietary basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time.
Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.
BactoByte has technology validation and partnerships with leading medical centers.
Company’s Keywords:
laboratory science, healthcare, medical device, rapid microbiology, in vitro diagnostics, biotechnology
<7
<
<2017
Your request has been submitted successfully.
Own or work here?